(Q43001342)

12 November 2017

title

Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses (English)

1 reference

12 November 2017

1 reference

1 reference

15

1 reference

12 November 2017

17

Michael Houghton

1 reference

12 November 2017

Angelica Medina-Selby

3

object named as

Angelica Medina-Selby

1 reference

12 November 2017

4

Doris Coit

1 reference

12 November 2017

1

Michael Vajdy

1 reference

12 November 2017

Mark Selby

2

1 reference

12 November 2017

John Hall

5

1 reference

12 November 2017

Laura Tandeske

6

1 reference

12 November 2017

David Chien

7

1 reference

12 November 2017

Celine Hu

8

1 reference

12 November 2017

Domenico Rosa

9

1 reference

12 November 2017

Manmohan Singh

10

1 reference

12 November 2017

Jina Kazzaz

11

1 reference

12 November 2017

Steve Nguyen

12

1 reference

12 November 2017

Steve Coates

13

1 reference

12 November 2017

Philip Ng

14

1 reference

12 November 2017

Yin-Ling Lin

16

1 reference

12 November 2017

Derek T O'Hagan

18

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Journal of General Virology

12 November 2017

published in

1 reference

12 November 2017

volume

87

1 reference

12 November 2017

issue

Pt 8

1 reference

12 November 2017

page(s)

2253-2262

1 reference

Analysis of successful immune responses in persons infected with hepatitis C virus

12 November 2017

cites work

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Immunological aspects of polymer microsphere vaccine delivery systems

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Deviation of the allergic IgE to an IgG response by gene immunotherapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

The scientific challenge of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Cationic microparticles are a potent delivery system for a HCV DNA vaccine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Charged polylactide co-glycolide microparticles as antigen delivery systems

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Synergistic adjuvant activity of immunostimulatory DNA and oil/water emulsions for immunization with HIV p55 gag antigen

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Modulating vaccine responses with dendritic cells and Toll-like receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Analysis of a successful immune response against hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Use of CpG oligodeoxynucleotides as immune adjuvants

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Microparticles as vaccine adjuvants and delivery systems

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Inhibition of Tumor Necrosis Factor (TNF-α)-mediated Apoptosis by Hepatitis C Virus Core Protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Aluminium compounds for use in vaccines

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Genetic organization and diversity of the hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

A Toll-like receptor recognizes bacterial DNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.81849-0

Identifiers

DOI

10.1099/VIR.0.81849-0

1 reference

12 November 2017

1 reference